N-butan-2-yl-N,2-dipropylpentan-1-amine;1-[4-[1-[(E)-3-[4-(2,3-dihydro-1H-indazol-5-yl)-2-methyl-3-pyridinyl]-2-methylprop-2-enyl]piperidin-4-yl]phenyl]ethanone;ethane;2-[(3-fluoro-4-methylcyclohexa-1,3-dien-1-yl)amino]-5-oxopentanamide
C63H102FN7O3 — CID 177355557
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-butan-2-yl-N,2-dipropylpentan-1-amine;1-[4-[1-[(E)-3-[4-(2,3-dihydro-1H-indazol-5-yl)-2-methyl-3-pyridinyl]-2-methylprop-2-enyl]piperidin-4-yl]phenyl]ethanone;ethane;2-[(3-fluoro-4-methylcyclohexa-1,3-dien-1-yl)amino]-5-oxopentanamide
N-butan-2-yl-N,2-dipropylpentan-1-amine;1-[4-[1-[(E)-3-[4-(2,3-dihydro-1H-indazol-5-yl)-2-methyl-3-pyridinyl]-2-methylprop-2-enyl]piperidin-4-yl]phenyl]ethanone;ethane;2-[(3-fluoro-4-methylcyclohexa-1,3-dien-1-yl)amino]-5-oxopentanamide (PubChem CID 177355557) has the molecular formula C63H102FN7O3 and a molecular weight of 1024.55 g/mol. Its IUPAC name is N-butan-2-yl-N,2-dipropylpentan-1-amine;1-[4-[1-[(E)-3-[4-(2,3-dihydro-1H-indazol-5-yl)-2-methyl-3-pyridinyl]-2-methylprop-2-enyl]piperidin-4-yl]phenyl]ethanone;ethane;2-[(3-fluoro-4-methylcyclohexa-1,3-dien-1-yl)amino]-5-oxopentanamide.
Molecular Properties
| Compound Name | N-butan-2-yl-N,2-dipropylpentan-1-amine;1-[4-[1-[(E)-3-[4-(2,3-dihydro-1H-indazol-5-yl)-2-methyl-3-pyridinyl]-2-methylprop-2-enyl]piperidin-4-yl]phenyl]ethanone;ethane;2-[(3-fluoro-4-methylcyclohexa-1,3-dien-1-yl)amino]-5-oxopentanamide |
|---|---|
| PubChem CID | 177355557 |
| Molecular Formula | C63H102FN7O3 |
| Molecular Weight | 1024.55 g/mol |
| Exact Mass | 1023.80 |
| IUPAC Name | N-butan-2-yl-N,2-dipropylpentan-1-amine;1-[4-[1-[(E)-3-[4-(2,3-dihydro-1H-indazol-5-yl)-2-methyl-3-pyridinyl]-2-methylprop-2-enyl]piperidin-4-yl]phenyl]ethanone;ethane;2-[(3-fluoro-4-methylcyclohexa-1,3-dien-1-yl)amino]-5-oxopentanamide |
| SMILES | CC.CC.CC.CC(=O)c1ccc(C2CCN(C/C(C)=C/c3c(-c4ccc5c(c4)CNN5)ccnc3C)CC2)cc1.CC1=C(F)C=C(NC(CCC=O)C(N)=O)CC1.CCCC(CCC)CN(CCC)C(C)CC |
| InChI | InChI=1S/C30H34N4O.C15H33N.C12H17FN2O2.3C2H6/c1-20(19-34-14-11-25(12-15-34)24-6-4-23(5-7-24)22(3)35)16-29-21(2)31-13-10-28(29)26-8-9-30-27(17-26)18-32-33-30;1-6-10-15(11-7-2)13-16(12-8-3)14(5)9-4;1-8-4-5-9(7-10(8)13)15-11(12(14)17)3-2-6-16;3*1-2/h4-10,13,16-17,25,32-33H,11-12,14-15,18-19H2,1-3H3;14-15H,6-13H2,1-5H3;6-7,11,15H,2-5H2,1H3,(H2,14,17);3*1-2H3/b20-16+;;;;; |
| InChIKey | OJAYKWZFWUOQSB-SLUUHYDUSA-N |
| XLogP | 15.09 |
| TPSA | 132.69 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 74 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1024.55 |
| LogP ≤ 5 | 15.09 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177355557 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.